公司概覽
業務類別 --
業務概覽 Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.
公司地址 Hegenheimermattweg 167b, Allschwil, CHE, 4123
電話號碼 +41 616061111
傳真號碼 +41 616061112
公司網頁 https://www.basilea.com
員工數量 189
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
沒有相關資料。
 
董事會成員
董事會 職務 更新日期
Dr. Nicole Onetto, M.D. Independent Director 17/02/2026
Mr. Stephan Schindler Chairman of the Board 17/02/2026
Dr. Martin Nicklasson, PhD Independent Director 17/02/2026
Dr. Thomas Werner, PhD Vice Chairman of the Board 17/02/2026
Mr. Leonard Kruimer Independent Director 17/02/2026
Dr. Carole Sable, M.D. Independent Director 17/02/2026
 
所屬ETF (更新日期: 02/05/2026 04:10)
代號 名稱 佔比% 持有日期
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.001%27/04/2026
IVSXApplied Finance IVS Intl SMID ETF0.001%29/04/2026
HSCZiShares Currency Hdgd MSCI EAFE SmCp ETF<0.000001%03/03/2026
  1   2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.